GlassScriptPhysician profile
Sheel B Patel
NPI 1871540146
$11,255.32
in general payments reported to CMS, 2019-2025
30 companies · $1,521 in 2025
The $1,521 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,468 · 2020: $363 · 2021: $3,154 · 2022: $1,998 · 2023: $1,980 · 2024: $771 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,272.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,358.06 | 2019-2025 | Clareon, Argos, Ngenuity |
| Glaukos Corporation | $1,818.96 | 2019-2021 | |
| Biotissue Holdings INC. | $1,451.91 | 2020-2025 | |
| Abbvie INC. | $1,242.18 | 2022-2025 | |
| Beaver-Visitec International, INC. | $960.22 | 2021-2022 | |
| Allergan, INC. | $627.42 | 2019-2022 | |
| Rxsight INC | $292.63 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $285.32 | 2019-2025 | |
| Kala Pharmaceuticals, INC. | $277.35 | 2019-2021 | |
| Dompe US, INC. | $268.83 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $234.69 | 2022-2024 | Toric, Miebo, Vyzulta |
| Johnson & Johnson Surgical Vision, INC. | $226.20 | 2019-2023 | Tecnis Iol |
| Ocular Therapeutix, INC. | $221.48 | 2019-2025 | Dextenza |
| Harrow Eye, LLC | $200.53 | 2023-2025 | Iheezo, Vevye |
| Sight Sciences, INC. | $161.63 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $133.54 | 2019-2023 | Callisto Eye, Artevo 800, Veracity Surgical |
| Alimera Sciences, INC. | $105.98 | 2019-2021 | |
| Oyster Point Pharma, INC. | $56.43 | 2022-2024 | Tyrvaya |
| Eyepoint US, INC. | $53.67 | 2020-2021 | |
| Notal Vision, INC. | $36.62 | 2024 | Foresee Home |
| Mallinckrodt Enterprises LLC | $32.21 | 2019 | |
| Mallinckrodt Hospital Products INC. | $30.27 | 2022 | |
| Amgen INC. | $30.14 | 2024 | Tepezza |
| Tearlab Corp | $29.11 | 2022-2024 | Scoutpro Osmolarity System |
| Aerie Pharmaceuticals, INC. | $26.10 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $24.13 | 2022 | |
| Merz Pharmaceuticals, LLC | $23.87 | 2021 | |
| New World Medical,INC. | $17.56 | 2023 | |
| Eyevance Pharmaceuticals LLC | $14.37 | 2019 | |
| Ivantis, INC | $13.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.